From: eNanoMapper: harnessing ontologies to enable data integration for nanomaterial risk assessment
Ontology detail | Availability | Primary content and focus |
---|---|---|
NanoParticle Ontology (NPO), [5] | Nanomaterial types, properties and experiments | |
Chemical Entities of Biological Interest (ChEBI), [6] | Chemical compounds, groups and roles, and nanomaterial types | |
Chemical information ontology (CHEMINF), [7] | Chemical qualities and descriptors, both calculated and measured | |
Chemical Methods Ontology (CHMO) | Chemical processes and experimental methods | |
Physico-Chemical Process Ontology (REX) | Chemical processes and experimental methods | |
Unit Ontology (UO), [8] | Units for measured or calculated quantities | |
Phenotype and Quality Ontology (PATO), [9] | Qualities and phenotypes | |
Ontology for Biomedical Investigations (OBI), [10] | Experiments and assays | |
BioAssay Ontology (BAO), [11] | Experiments and assays | |
Gene Ontology (GO), [12] | Molecular functions, biological processes and cellular components | |
Protein Ontology (PRO), [13] | Proteins and protein complexes | |
Cell Ontology (CL), [14] | Cell types | |
Cell Culture Ontology (CCONT), [15] | Cell lines | |
UBERON, [16] | Multi-species anatomy | |
Environment Ontology (ENVO), [17] | Environments such as soil and sediment | |
Ontology of Adverse Events (OAE), [18] | Adverse events of a medical nature |